Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SUMO1 antibody

The Mouse Monoclonal anti-SUMO1 antibody has been validated for WB, IF, FACS and IHC (f). It is suitable to detect SUMO1 in samples from Human.
Catalog No. ABIN6938466

Quick Overview for SUMO1 antibody (ABIN6938466)

Target

See all SUMO1 Antibodies
SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))

Reactivity

  • 97
  • 80
  • 74
  • 6
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 102
  • 33
  • 3
  • 1
  • 1
Mouse

Clonality

  • 94
  • 47
Monoclonal

Conjugate

  • 73
  • 10
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SUMO1 antibody is un-conjugated

Application

  • 115
  • 50
  • 49
  • 43
  • 34
  • 27
  • 26
  • 23
  • 19
  • 13
  • 7
  • 7
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

SM1-495
  • Specificity

    This MAb is specific to SUMO-1 and shows no cross-reaction with either SUMO-2 or SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, SUMO-2 and SUMO-3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2, and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1 protein localizes to the nuclear membrane.

    Cross-Reactivity (Details)

    Human. Rat. Predicted to show a broad species reactivity.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human SUMO1 protein

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Breast Carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))

    Alternative Name

    SUMO1

    Background

    GAP-modifying protein 1, GMP1, OFC10, PIC1, SENP2, Sentrin 1, Small ubiquitin-related modifier 1, SMT3, SMT3 suppressor of mif two 3 homolog 1, SMT3C, SMT3H3, Ubiquitin homology domain protein PIC1, Ubiquitin Like 1, Ubiquitin like protein UBL1,SUMO-1
    Cellular localisation: Predominantly nuclear with some cytoplasmic

    Molecular Weight

    11.5kDa (Monomer), 90kDa (Heteromer)

    Gene ID

    7341, 596171

    UniProt

    P63165

    Pathways

    M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
You are here:
Chat with us!